Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

doi:10.1016/j.jns.2020.116803

Practice Guideline

. 2020 May 15:412:116803.

doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Affiliations

¹ Department of Neurology, Institute of Immunology and Immunotherapy, University Hospitals, Birmingham B15 2TH, United Kingdom. Electronic address: saiju.jacob@uhb.nhs.uk.
² Department of Neurology, Stanford Neuroscience Health Center, Palo Alto, CA 94304, USA. Electronic address: muppidis@stanford.edu.
³ Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.
⁴ Department of Neurology, Duke University Medical Center, Durham, NC 27710, USA.
⁵ Department of Neurology, University of Vermont Medical Center, Burlington, VT 05401, USA.
⁶ Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7025, USA.
⁷ Catedràtica Neurologia U.A.B., Unitat Patologia Neuromuscular, Servei Neurologia, Hospital Santa Creu i Sant Pau, C/ Pare Claret 167, Barcelona 08025, Spain.
⁸ Department of Neuroimmunology and Neuromuscular Diseases, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milano, Italy.
⁹ Department of Neurology, School of Medicine, International University of Health and Welfare, Narita, Japan.
¹⁰ Department of Neurology, Hanamaki General Hospital, Japan.
¹¹ Department of Neurology, 2082 Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
¹² Department of Neurology, Institute of Translational Neurology, University of Münster, Münster, Germany.
¹³ Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: richard.nowak@yale.edu.

PMID: 32247193
PMCID: PMC7105910
DOI: 10.1016/j.jns.2020.116803

Practice Guideline

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

International MG/COVID-19 Working Group et al. J Neurol Sci. 2020.

. 2020 May 15:412:116803.

doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.

Affiliations

¹ Department of Neurology, Institute of Immunology and Immunotherapy, University Hospitals, Birmingham B15 2TH, United Kingdom. Electronic address: saiju.jacob@uhb.nhs.uk.
² Department of Neurology, Stanford Neuroscience Health Center, Palo Alto, CA 94304, USA. Electronic address: muppidis@stanford.edu.
³ Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.
⁴ Department of Neurology, Duke University Medical Center, Durham, NC 27710, USA.
⁵ Department of Neurology, University of Vermont Medical Center, Burlington, VT 05401, USA.
⁶ Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7025, USA.
⁷ Catedràtica Neurologia U.A.B., Unitat Patologia Neuromuscular, Servei Neurologia, Hospital Santa Creu i Sant Pau, C/ Pare Claret 167, Barcelona 08025, Spain.
⁸ Department of Neuroimmunology and Neuromuscular Diseases, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milano, Italy.
⁹ Department of Neurology, School of Medicine, International University of Health and Welfare, Narita, Japan.
¹⁰ Department of Neurology, Hanamaki General Hospital, Japan.
¹¹ Department of Neurology, 2082 Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
¹² Department of Neurology, Institute of Translational Neurology, University of Münster, Münster, Germany.
¹³ Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: richard.nowak@yale.edu.

PMID: 32247193
PMCID: PMC7105910
DOI: 10.1016/j.jns.2020.116803

No abstract available

PubMed Disclaimer

Comment in

Myasthenic crisis in COVID-19.
Delly F, Syed MJ, Lisak RP, Zutshi D. Delly F, et al. J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6. J Neurol Sci. 2020. PMID: 32413767 Free PMC article.
Management of patients with generalised myasthenia gravis and COVID-19: four case reports.
Hübers A, Lascano AM, Lalive PH. Hübers A, et al. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1124-1125. doi: 10.1136/jnnp-2020-323565. Epub 2020 Jul 10. J Neurol Neurosurg Psychiatry. 2020. PMID: 32651248 No abstract available.

Cited by

Myasthenia gravis and coronavirus disease 2019: A report from Iran.
Etemadifar M, Akafzadeh-Savari M, Salari M, Akhavan Sigari A, Ebrahimi-Pelarti S, Sedaghat N, Etemad K. Etemadifar M, et al. Curr J Neurol. 2021 Jul 6;20(3):162-165. doi: 10.18502/cjn.v20i3.7692. Curr J Neurol. 2021. PMID: 38011410 Free PMC article.
Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study.
Zhou S, Wen Y, Liu C, Zhong J, Liang M, Wu Y, Lv S, Gong Z, Lao D, Li T, Lu T, Tang J, Mo X, Huang W. Zhou S, et al. J Inflamm Res. 2023 Jul 26;16:3157-3168. doi: 10.2147/JIR.S419307. eCollection 2023. J Inflamm Res. 2023. PMID: 37525635 Free PMC article.
Health-related quality of life (HRQoL) and psychological impact of the COVID-19 pandemic on patients with myasthenia gravis.
García I, Martínez O, López-Paz JF, Salgueiro M, Rodríguez AA, Zorita J, García-Sanchoyerto M, Amayra I. García I, et al. Intractable Rare Dis Res. 2023 May;12(2):88-96. doi: 10.5582/irdr.2023.01003. Intractable Rare Dis Res. 2023. PMID: 37287657 Free PMC article.
Neuromuscular Disorders Associated With COVID-19.
Morgan L, Hollist M, Au K, Ayari L, Betts C, Kirmani BF. Morgan L, et al. Neurosci Insights. 2023 May 25;18:26331055231176251. doi: 10.1177/26331055231176251. eCollection 2023. Neurosci Insights. 2023. PMID: 37255741 Free PMC article. Review.
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases.
Hamidi Z, Jabraeili-Siahroud S, Taati-Alamdari Y, Aghbash PS, Shamekh A, Baghi HB. Hamidi Z, et al. Virol J. 2023 Jan 7;20(1):1. doi: 10.1186/s12985-023-01967-7. Virol J. 2023. PMID: 36611166 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- Genetic Alliance
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Affiliations

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Authors

Affiliations

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical